Efectivo Y Equivalentes Cambio Fecha
Agios Pharmaceuticals USD 89.13M 3.58M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Arrowhead Research USD 201.64M 112.94M 2025-12
Astellas Pharma JPY 188.37B 8.51B 2025-03
BioCryst Pharmaceuticals USD 335.91M 251.83M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Celltrion KRW 29.65B 799.42B 2025-06
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Deva Holding AS TRY 775.92M 574.67M 2023-09
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Exelixis USD 482.49M 106.19M 2025-12
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
Kangmei Pharma CNY 1.18B 278M 2025-09
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Moderna USD 2.6B 1.46B 2025-12
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Neurocrine Biosciences USD 713M 372.8M 2025-12
Novartis USD 9.56B 2.9B 2025-09
Omeros USD 1.9M 2.36M 2025-06
OPKO Health USD 369.1M 42.87M 2025-12
Organigram Holdings CAD 7.58M 20.62M 2025-12
Pfizer USD 1.34B 295M 2025-09
Pharma Mar EUR 17.82M 3.78M 2025-12
PTC Therapeutics USD 984.65M 312.03M 2025-12
Qiagen NV USD 1.36B 621.78M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Sartorius EUR 389.9M 429.1M 2025-09
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tilray USD 264.83M 43.16M 2025-06
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12
Zealand Pharma A/S 4.58B 1.4B 2025-12
Zz Pientze Pharmaceu CNY 1.77B 376.03M 2025-06